Dual Trigger With HCG and GnRH Agonist on Thawed Modified Natural Cycle Embryo Transfer

National Taiwan University

Status and phase: Not yet enrolling; Phase 4

Conditions: In Vitro Fertilization (IVF); Embryo Transfer

Treatments: Drug: GnRH agonist

Study type: Interventional

Funder types: Other

Identifiers

NCT07269392

202409081MINB

Details and patient eligibility

About

Impact of dual trigger using recombinant human chorionic gonadotropin (HCG) and gonadotropin-releasing hormone (GnRH) agonist on thawed modified natural cycle outcomes: an open-label multi-center randomized controlled trial.

Enrollment: 170 estimated patients

Sex: Female

Ages: 25 to 44 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. 24<= Age < 45 patient undergo mNC-FET

Exclusion criteria

1. Congenital or acquired uterine abnormalities (uterine malformation, submucosal myoma, intrauterine adhesion or endometrial polyp >1cm)

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

170 participants in 2 patient groups

dual

Experimental group

Description:

GnRH agonist

Treatment:

Drug: GnRH agonist

hcg

No Intervention group

Description:

hcg